CEO: Daniel Tassé
Employees: 106
IPO: Oct 22, 2014
Price
$21.06
Change
▲ $0.56
2.73%
Mkt Cap
503.79M
Day Range
$19.89
$21.33
52-Week Range
$6.00
$26.19
Volume
445,419
50D / 200D Avg
$21.55
$15.04
Prev Close
$20.50
Quick Summary
Key Takeaways
Debt/Equity of 0.13 — conservative balance sheet
Negative free cash flow of -121.18M
PEG of 0.36 suggests growth is underpriced
Growth
Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Quality
Return on Equity
-150.29%
Below sector avg (3.46%)
ROIC-60.32%
Net MarginN/A
Op. MarginN/A
Safety
Debt / Equity
0.13
Below sector avg (0.23)
Current Ratio3.67
Interest Coverage0.00
Valuation
P/E Ratio
-3.42
Below sector avg (0.22)
Forward P/EN/A
P/B Ratio2.99
EV/EBITDAN/A
Dividend Yield0.00%
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (640 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | -3.4 | 0.2 |
| P/B | 3.0 | 2.9 |
| ROE % | -150.3 | 3.5 |
| Net Margin % | — | 3.9 |
| Rev Growth 5Y % | — | 9.6 |
| D/E | 0.1 | 0.2 |
Dividend History
Yield
0.00%
Payout Ratio
0.00%
Growth (3Y)
N/A
Growth (5Y)
N/A
No dividend history available.
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 0.0 | Net Income (TTM) | -147.40M |
| ROE | -150.29% | ROA | -63.07% |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | N/A | Free Cash Flow (TTM) | -121.18M |
| ROIC | -60.32% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.13 | Current Ratio | 3.67 |
| Interest Coverage | 0.00 | ||
| Dividends | |||
| Dividend Yield | 0.00% | Payout Ratio | 0.00% |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -3.42 | Forward P/E | N/A |
| P/B Ratio | 2.99 | P/S Ratio | N/A |
| PEG Ratio | 0.36 | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | N/A |
| FCF Yield | -24.05% | ||
| Market Cap | 503.79M | Enterprise Value | 331.31M |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 0.0 | 0.0 | 15.73M | 4.80M | 5.71M |
| Net Income | -147.40M | -113.72M | -72.73M | -96.30M | -97.81M |
| EPS (Diluted) | -5.30 | -5.90 | -3.80 | -6.20 | -8.90 |
| Gross Profit | -17.67M | -6.81M | 15.73M | -15.50M | -3.57M |
| Operating Income | -153.16M | -120.53M | -76.43M | -96.63M | -98.61M |
| EBITDA | -135.49M | -110.99M | -63.27M | -76.68M | -91.16M |
| R&D Expenses | 22.78M | 89.90M | 60.22M | 75.50M | 70.34M |
| SG&A Expenses | 17.24M | 23.81M | 31.94M | 17.56M | 23.83M |
| D&A | 17.67M | 6.81M | 13.16M | 20.30M | 8.38M |
| Interest Expense | 0.0 | 0.0 | 0.0 | 427,000.0 | 690,000.0 |
| Income Tax | -5.16M | -4.08M | 7,000.0 | 70,000.0 | -381,000.0 |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 233.72M | 65.66M | 182.99M | 246.52M | 146.32M |
| Total Liabilities | 64.95M | 38.27M | 42.80M | 52.07M | 47.29M |
| Shareholders' Equity | 168.77M | 27.39M | 140.19M | 194.45M | 99.03M |
| Total Debt | 21.68M | 7.80M | 6.55M | 4.15M | 10.66M |
| Cash & Equivalents | 194.17M | 32.46M | 141.37M | 209.19M | 77.30M |
| Current Assets | 212.94M | 44.39M | 158.92M | 223.07M | 114.52M |
| Current Liabilities | 58.03M | 31.14M | 37.34M | 29.52M | 31.40M |